The study suggests that rotavirus G9 was reintroduced into Argentina as a novel G9P[8] strain rather than evolving from previously circulating G9P[6] strains.
No takes yet. Share an insight, caveat, or question.
Supports enhanced rotavirus surveillance in Argentina; leaves open implications for current vaccine formulations.
Stupka et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: